UNITED STATES SEMEN ANALYSIS MARKET FORECAST 2025-2032

Additionally, the expansion of fertility clinics and ART centers, and growing awareness of fertility testing and reproductive health across the United States ensures broader access to reliable diagnostic solutions. This progress is also contributing to the future demand in the semen analysis market, which is expected to grow with increased focus on laboratory testing of semen and improvements in the semen analysis procedure.

Semen analysis technologies are projected to witness continued growth, with computer-assisted semen analysis (CASA) systems playing a pivotal role. CASA systems combine advanced imaging and computational semen analysis tools to provide accurate and standardized results, reducing variability in manual assessments.

Their adoption is expected to increase significantly, especially in fertility clinics and diagnostic laboratories. Moreover, the rising demand for sperm count home testing kit options reflects a shift towards comfort and convenience-centered patient care, driven by accessibility and the need for privacy.

This shift also aligns with the growing popularity of male fertility test options, which provide individuals with a convenient method for assessing their reproductive health. Furthermore, advancements in semen quality assessment are driving improvements in diagnostic accuracy, while the increasing use of male fertility supplements is contributing to overall market growth.

The United States Semen Analysis Market: 6.16% CAGR (2025-2032)

Need a custom report or have specific data requirements? Let us know!

The United States semen analysis market is segmented into diagnostic technique, testing kits and reagents, age group, and end-user. The diagnostic technique category is further classified into microscopic examination, computer-assisted semen analysis (CASA), and other diagnostic techniques.

Microscopic examination remains a widely used technique for semen analysis, particularly in clinical settings, due to its cost-effectiveness and ability to meet basic diagnostic needs. This traditional technique enables the direct observation of sperm count, motility, and morphology, providing healthcare professionals with valuable insights into male reproductive health. 

Despite the emergence of advanced technologies, microscopic examination continues to be favored due to its accessibility, simplicity, and ability to deliver accurate results with minimal equipment. Ongoing advancements in microscopy, such as improved imaging clarity and enhanced staining techniques, are further refining the precision and ease of this method, ensuring its continued relevance in the market. 

Major companies operating in the United States semen analysis market include bioMérieux SA, Cooper Companies, Inc, DNA Diagnostics Center, Hamilton Thorne Inc, etc. 

Hamilton Thorne Inc specializes in the design, manufacture, and marketing of precision instruments, consumables, software, and services for Assisted Reproductive Technologies (ART), research, and cell biology markets. 

The company’s product portfolio includes precision laser systems, Computer Assisted Sperm Analysis (CASA) systems, imaging systems, and related consumables, serving fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, and biotechnology firms. Operating globally, Hamilton Thorne has facilities and a network of distributors across North America, Europe, and other regions.